These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29512096)

  • 21. Characteristics of ST-elevation myocardial infarction with failed thrombolysis.
    Mishra A; Prajapati J; Dubey G; Patel I; Mahla M; Bishnoi S; Pandey V
    Asian Cardiovasc Thorac Ann; 2020 Jun; 28(5):266-272. PubMed ID: 32493040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA
    Luo J; Dai L; Li J; Zhao J; Li Z; Qin X; Li H; Liu B; Wei Y
    Clin Interv Aging; 2018; 13():1099-1109. PubMed ID: 29922048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of CHA2DS2-VASc Score for Prediction and Ruling Out of Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention.
    Açikgöz SK; Açikgöz E; Çiçek G
    Angiology; 2020 May; 71(5):411-416. PubMed ID: 32030991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHA2DS2-VASc score predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction, who have undergone primary percutaneous coronary intervention.
    Cicek G; Yıldırım E
    Kardiol Pol; 2018; 76(1):91-98. PubMed ID: 28980300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Red cell distribution width is a predictor of ST resolution and clinical outcome following thrombolysis in acute ST elevation myocardial infarction.
    Ghaffari S; Pourafkari L; Sepehrvand N; Aslanabadi N; Faridi L; Tajlil A; Masoumi N; Nader ND
    Thromb Res; 2016 Apr; 140():1-6. PubMed ID: 26896606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Int J Clin Pract; 2022; 2022():3659381. PubMed ID: 36225534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Lesion Complexity and the CHA
    Alıcı G; Barman HA; Atıcı A; Tuğrul S; Genç Ö; Şahin İ
    Int J Clin Pract; 2022; 2022():8066780. PubMed ID: 35685511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of the red cell distribution width and neutrophil/lymphocyte ratio in predicting thrombolysis failure in patients with an ST-segment elevation myocardial infarction.
    Baysal E; Çetin M; Yaylak B; Altntaş B; Altndağ R; Adyaman Ş; Altaş Y; Kaya İ; Sevuk U
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):274-8. PubMed ID: 25396765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New R
    Zhang Q; Hu M; Ma S; Niu T
    Front Cardiovasc Med; 2022; 9():899739. PubMed ID: 36312233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of CHA
    Sun Y; Ren J; Wang W; Wang C; Li L; Yao H
    Clin Cardiol; 2023 Aug; 46(8):950-957. PubMed ID: 37430484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHA
    Modi R; Patted SV; Halkati PC; Porwal S; Ambar S; Mr P; Metgudmath V; Sattur A
    Int J Cardiol; 2017 Feb; 228():1002-1006. PubMed ID: 27915215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of CHA2DS2-VASc score with successful recanalization in acute ischemic stroke patients undergoing endovascular thrombectomy.
    Nasifov M; Ozmen E; Deniz C; Nadir A; Ozden O; Bingol G; Jafarov P; Asil T; Goktekin O; Sari I
    Postepy Kardiol Interwencyjnej; 2022 Sep; 18(3):269-275. PubMed ID: 36751289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CHA
    Cozac DA; Lakatos EK; Demjen Z; Ceamburu A; Fișcă PC; Șuș I; Hadadi L; Scridon A
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragmented QRS (fQRS) Complex Predicts Adverse Cardiac Events of ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention and Thrombolysis.
    Xia W; Feng XY
    Med Sci Monit; 2018 Jul; 24():4634-4640. PubMed ID: 29974889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Risk Scoring System to Predict Cardiovascular Death in Patients With Acute Myocardial Infarction: CHA
    Kundi H; Kiziltunc E; Korkmaz A; Cicek G; Ornek E; Ileri M
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):273-278. PubMed ID: 28627231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.
    Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L
    J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive Value of CHA2DS2-VASc Score in Patients with Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Elevated Myocardial Infarction.
    Dönmez E; Özcan S; İnce O; Şahin İ; Okuyan E
    Turk Kardiyol Dern Ars; 2023 Mar; 51(2):97-103. PubMed ID: 36916809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CHA2DS2-VASc Risk Score Predicts Total Occlusion in Infarct-Related Arteries in Patients With Non-ST Elevation Myocardial Infarction.
    Yaşar E; Bayramoğlu A; Karakuş Y; Çakmak T
    Angiology; 2022 Apr; 73(4):380-386. PubMed ID: 34275378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.
    Hudzik B; Szkodziński J; Hawranek M; Lekston A; Poloński L; Gąsior M
    Acta Diabetol; 2016 Oct; 53(5):807-15. PubMed ID: 27339195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.